news Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 202409/04/2024Trevi Therapeutics to Participate in September Investor and Medical Conferences08/28/2024Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance08/08/2024 VIEW ALL NEWS contact Trevi Therapeutics 195 Church Street, 16th Floor New Haven, CT 06510 map (203) 304-2499 email us
